IRVINE, Calif., Dec. 6, 2006 (PRIME NEWSWIRE) -- "Sports Illustrated once referred to this dubious era of sports tainted by steroids and other doping as the Asterisk Era, noting the lingering doubt that exists regarding athletic achievement of all varieties," said SmallCap Sentinel analyst D.R. Clark. "We now question excellence with an omnipresent suspicion, wondering aloud if they're clean."
"Sports leagues and anti-doping agencies are making an effort to remove the asterisk, looking to improve testing for athletes and increasing punishment for offenders," Clark added. "We're also seeing LEGITIMATE products attaining certifications from anti-doping laboratories."
"Along these lines, Millennium Biotechnologies, Inc. (OTCBB:MBTG) announced that its Resurgex products are now tested and certified not to contain banned substances by the Banned Substance Control Group's (BSCG) certification program. This is the only certification program in the U.S. that uses a World Anti Doping Agency accredited laboratory to detect for dangerous banned substances in nutritional supplements."
Millennium Biotechnologies, Inc. is a wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. MBTG is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements. MBTG's flagship products include: RESURGEX(r), RESURGEX Plus(tm), and RESURGEX Select(tm), and are designed to assist in reducing fatigue and oxidative stress, maintaining lean muscle, and immune support in immunocompromised conditions.
A detailed report regarding Millennium Biotechnologies, Inc. is available free to the investing public at the following link:
http://stockupticks.com/profiles/11-28-06.html
The report "Better Mousetrap Files" has been made available free of charge at www.SmallCapSentinel.com and will address preeminent and emerging companies such as N B T Y Inc. (NYSE:NTY), Schiff Nutrition International, Inc. (NYSE:WNI), Nutrition 21 Inc (Nasdaq:NXXI), and Millennium Biotechnologies.
Individuals may also register to receive future reports on emergent public companies at:
http://stockupticks.com/register.html
To be featured in SmallCap Sentinel or StockUpTicks.com please use the contact information below or email sts@marketpathways.com
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $24,000 by Millennium Biotechnologies. for preparation and distribution of this report and other advertising services over a 90-day period. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding subject companies.